Holen Sie sich die Stockscreener-App
23.84
3.24%
-0.70
Schlusskurs vom Vortag:
$24.54
Offen:
$23.66
24-Stunden-Volumen:
357.82K
Relative Volume:
0.46
Marktkapitalisierung:
$1.46B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-217.34M
KGV:
-5.7881
EPS:
-4.1188
Netto-Cashflow:
$-127.29M
1W Leistung:
-5.62%
1M Leistung:
+7.93%
6M Leistung:
+156.70%
1J Leistung:
+524.87%
1-Tages-Spanne:
$22.80
$24.38
1-Wochen-Bereich:
$22.80
$27.34
52-Wochen-Spanne:
$1.92
$31.18
Kodiak Sciences Inc Stock (KOD) Company Profile
Firmenname
Kodiak Sciences Inc
Sektor
Branche
Telefon
650-281-0850
Adresse
1250 PAGE MILL RD, PALO ALTO, CA
Compare KOD vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
23.89 | 1.50B | 0 | -217.34M | -127.29M | -4.1188 |
|
VRTX
Vertex Pharmaceuticals Inc
|
478.18 | 125.08B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
756.53 | 81.90B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
708.68 | 45.06B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.50 | 42.50B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
287.36 | 33.16B | 5.36B | 287.73M | 924.18M | 2.5229 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-11 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-10-24 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-09-25 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-09-22 | Eingeleitet | Jefferies | Buy |
| 2025-08-14 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-12-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-09-05 | Eingeleitet | H.C. Wainwright | Neutral |
| 2023-12-11 | Fortgesetzt | Goldman | Sell |
| 2023-11-17 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2023-07-27 | Herabstufung | UBS | Buy → Neutral |
| 2023-07-25 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2023-07-25 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-07-24 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2023-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2022-11-15 | Eingeleitet | CapitalOne | Overweight |
| 2022-08-02 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-02-24 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-05-11 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2021-03-12 | Eingeleitet | Evercore ISI | Outperform |
| 2021-03-01 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2021-02-17 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2021-01-25 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-12-11 | Eingeleitet | Citigroup | Neutral |
| 2020-11-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-11-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-13 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-31 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-03-03 | Eingeleitet | Goldman | Buy |
| 2020-02-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-02-06 | Eingeleitet | SunTrust | Buy |
| 2020-01-08 | Eingeleitet | ROTH Capital | Buy |
| 2020-01-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-24 | Eingeleitet | JP Morgan | Overweight |
| 2019-10-15 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-02-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-10-29 | Eingeleitet | Barclays | Overweight |
| 2018-10-29 | Eingeleitet | BofA/Merrill | Buy |
| 2018-10-29 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Kodiak Sciences Inc Aktie (KOD) Neueste Nachrichten
Kodiak Sciences Stock Up 480% as One Fund Discloses $53 Million Buy - AOL.com
Big Money Moves: What is the Moat Score of Kodiak Sciences IncWeekly Trend Summary & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing - Yahoo Finance
Market Wrap: Will Kodiak Sciences Inc benefit from AI trends2026 Pullbacks & Comprehensive Market Scan Insights - baoquankhu1.vn
TD Asset Management Inc Acquires New Stake in Kodiak Sciences Inc. $KOD - MarketBeat
Growth Value: What are the analyst revisions for Kodiak Sciences IncIs BOIL stock a good investment in YEAR - baoquankhu1.vn
Kodiak Sciences Inc. (NASDAQ:KOD) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Will Kodiak Sciences Inc face regulatory challenges2025 Price Targets & Weekly High Potential Stock Alerts - baoquankhu1.vn
Aug Retail: Is Kodiak Sciences Inc a turnaround storyJuly 2025 Setups & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Assessing Kodiak Sciences (KOD) Valuation After Baker Bros. Buying And Late Stage Retinal Trial Progress - simplywall.st
Kodiak Sciences (KOD) Price Target Increased by 15.58% to 36.21 - Nasdaq
Can Kodiak Sciences Inc. outperform in the next rallyPortfolio Performance Summary & Daily Stock Trend Watchlist - mfd.ru
A Look At Kodiak Sciences (KOD) Valuation After Its Strong One Year Shareholder Return - Yahoo Finance
Earnings Miss: Is Kodiak Sciences Inc stock a smart retirement pickJuly 2025 Market Mood & Fast Gain Stock Tips - baoquankhu1.vn
Kodiak Sciences (NASDAQ:KOD) Shares Down 5.9%Here's What Happened - MarketBeat
First Week of April 17th Options Trading For Kodiak Sciences (KOD) - Nasdaq
Will Kodiak Sciences Inc. stock remain a Wall Street favoriteJuly 2025 Market Mood & Risk Managed Investment Signals - mfd.ru
Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead - AOL.com
History Review: Is Kodiak Sciences Inc a turnaround story2025 Performance Recap & Growth Focused Entry Reports - baoquankhu1.vn
Kodiak Sciences (NASDAQ:KOD) Shares Up 10.9%Should You Buy? - MarketBeat
GSA Capital Partners LLP Sells 76,735 Shares of Kodiak Sciences Inc. $KOD - MarketBeat
Perlroth reports 9.9% Kodiak Sciences (KOD) stake in 13G/A - Stock Titan
Will Kodiak Sciences Inc. benefit from seasonality2025 EndofYear Setup & AI Powered Buy/Sell Recommendations - mfd.ru
Will Kodiak Sciences Inc. benefit from AI trendsQuarterly Investment Review & Low Risk Growth Stock Ideas - mfd.ru
Will Kodiak Sciences Inc. outperform the market in YEAREarnings Recap Summary & Verified Entry Point Signals - mfd.ru
Will Kodiak Sciences Inc. stock outperform tech sector in 2025July 2025 Weekly Recap & AI Enhanced Market Trend Forecasts - mfd.ru
KOD Technical Analysis & Stock Price Forecast - Intellectia AI
KOD PE Ratio & Valuation, Is KOD Overvalued - Intellectia AI
Smart Money: Will Kodiak Sciences Inc benefit from AI trendsJuly 2025 Volume & Technical Pattern Alert System - baoquankhu1.vn
What are the analyst revisions for Kodiak Sciences Inc.Is BOIL stock a good investment in YEARJuly 2025 Technicals & Weekly Market Pulse Alerts - mfd.ru
H.C. Wainwright reiterates Buy rating on Kodiak Sciences stock at $38 - Investing.com Nigeria
H.C. Wainwright reiterates Buy rating on Kodiak Sciences stock at $38 By Investing.com - Investing.com South Africa
KOD: HC Wainwright & Co. Reiterates Buy Rating with $38 Target | - GuruFocus
HC Wainwright Reaffirms Buy Rating for Kodiak Sciences (NASDAQ:KOD) - MarketBeat
Kodiak Sciences Inc. (KOD) Presents at Angiogenesis, Exudation, and Degeneration 2026Slideshow - Seeking Alpha
Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares - Eastern Progress
KOD Stock Up 24% in 3 Months: Here's What You Need to Know - TradingView
Aug PostEarnings: Can Kodiak Sciences Inc lead its sector in growthEarnings Miss & Precise Entry and Exit Recommendations - baoquankhu1.vn
Kodiak Sciences Inc. (NASDAQ:KOD) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Kodiak Sciences to present final APEX study results at Angiogenesis meeting - Investing.com Nigeria
Kodiak Sciences to present final APEX study results at Angiogenesis meeting By Investing.com - Investing.com South Africa
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026 - marketscreener.com
Kodiak Sciences (KOD) Price Target Increased by 11.69% to 31.33 - Nasdaq
Kodiak Sciences raises capital through completed stock offering - MSN
Kodiak Sciences: A Stellar Move (NASDAQ:KOD) - Seeking Alpha
Kodiak Sciences: GLOW2 Readout as Key Catalyst for Tarcocimab Upside and Broader Pipeline Optionality - TipRanks
Aug Catalysts: Is Kodiak Sciences Inc exposed to currency risks2025 Volatility Report & Capital Protection Trading Alerts - baoquankhu1.vn
Aug Retail: Will Kodiak Sciences Inc outperform the market in YEAR - baoquankhu1.vn
Kodiak Sciences (NASDAQ:KOD) Trading 6.5% HigherHere's Why - MarketBeat
Can Kodiak Sciences (KOD) Funding And Readouts Reshape Its Retinal Disease Treatment Narrative? - Sahm
Finanzdaten der Kodiak Sciences Inc-Aktie (KOD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kodiak Sciences Inc-Aktie (KOD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BORGESON JOHN A. | See Remarks |
Jun 17 '25 |
Sale |
3.65 |
723 |
2,640 |
183,316 |
1.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):